James Molloy

Stock Analyst at Alliance Global Partners

(0.33)
# 4,189
Out of 4,918 analysts
33
Total ratings
20.59%
Success rate
-43.12%
Average return

Stocks Rated by James Molloy

Soligenix
Jul 16, 2025
Maintains: Buy
Price Target: $10$6
Current: $2.74
Upside: +118.98%
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.34
Upside: +925.19%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.24
Upside: +3,456.49%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $14.58
Upside: +140.14%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.72
Upside: +1,969.82%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $2.56
Upside: +681.25%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $13.41
Upside: +3,553.99%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600$1,100
Current: $39.01
Upside: +2,719.79%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.62
Upside: +180.76%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.81
Upside: +256.26%
Maintains: Buy
Price Target: $9$14
Current: $0.73
Upside: +1,829.70%
Initiates: Buy
Price Target: $30
Current: $1.49
Upside: +1,909.65%
Initiates: Buy
Price Target: $7.5
Current: $1.08
Upside: +594.44%
Reiterates: Buy
Price Target: $20
Current: $6.50
Upside: +207.69%
Maintains: Buy
Price Target: $14$8
Current: $1.66
Upside: +381.93%
Maintains: Buy
Price Target: $10$7
Current: $3.82
Upside: +83.25%
Initiates: Buy
Price Target: $80
Current: $1.01
Upside: +7,820.79%
Initiates: Buy
Price Target: $16
Current: $0.44
Upside: +3,573.09%
Initiates: Buy
Price Target: $14
Current: $0.31
Upside: +4,460.26%
Initiates: Buy
Price Target: $225
Current: $8.50
Upside: +2,547.06%
Initiates: Buy
Price Target: $8,400
Current: $6.82
Upside: +123,067.16%
Initiates: Buy
Price Target: $150
Current: $3.12
Upside: +4,707.69%
Initiates: Buy
Price Target: $938
Current: $1.15
Upside: +81,421.74%
Initiates: Buy
Price Target: $25
Current: $2.55
Upside: +880.39%